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BACKGROUND: Allergic asthma is a degenerative atopic disease caused by allergic or hypersensitivity type-1. More than 50% of people with allergic 
asthma are caused by the presence of house dust mites 
(HDMs) allergens. 
METHODS: The cellular immunity response was evaluated 
through a peripheral blood mononuclear cell (PBMC) culture 
isolated from blood, using the ficoll gradient technique. 
Subjects were atopic asthma groups and non-atopic asthma 
groups. PBMC from each subject cultured was stimulated 
with HDMs allergen, then incubated in a CO2 5% incubator, 
37oC for 72 hours. With the multiplex assay method, 
interferon (IFN)-γ, interleukin (IL)-13 and IL-10 were 
measured, meanwhile indoleamine 2,3-dioxygenase level 
(IDO) was measured by the enzyme-linked immunosorbent 
assay (ELISA) sandwich methods. 
RESULTS: The IFN-γ production in the supernatant of 
PBMC cultures was stimulated by phytohemagglutinin 
(PHA), Roswell Park Memorial Institute (RPMI) medium 
and allergens. The IFN-γ production in allergen-stimulated 
supernatants showed higher level of IFN-γ in the non-
atopic group (4,681,455±3,434,851) than atopic group 
(4,363,300±2,067,941) even though it was not statistically 
significant (p=0.078). There were no differences between 
the mean of IL-13 production in atopic asthma group 
and non-atopic group. The IL-10 production in allergen-
stimulated supernatants was shown to be higher in non-
atopic group and were statistically significantly different 
(p=0.015). The IDO production in allergen-stimulated 
supernatants was shown to be higher in the non-atopic group 
(272,231±269,564) than in the actopic group (13,273±400), 
and it was significantly different (p=0.007).
CONCLUSION: Cellular immune profile of subjects with 
allergic  asthma  to  Dermatophagoides  pterronyssinus (Der 
p) is characterized by a type-2 inflammatory response that 
is dominant compared to type-1 inflammation (higher IL-13 
ratio compared to IFN-γ) and to the role of anti-inflammation 
(higher IL-13 ratio compared to IL-10). The decline in IDO 
production in allergic asthma subjects to Der p is thought to 
be related to the low cellular immune response in expressing 
IFN-γ compared to IL-13.
KEywORDS: interleukin-13, interleukin-10, IDO, 
PBMC, asthma
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Introduction
Allergic diseases are the most common disorders of immunity 
in the entire world. More than 30% of the world population 
has allergic symptoms whose pattern of abnormalities 
is categorized as type-1 hypersensitivity.(1) In the last 
decade, diseases that are based on allergic mechanisms such 
as rhinitis, bronchial asthma, and prevalence dermatitis 
continue to increase. The prevalence of asthma in the world 
has increased in the past few decades, estimated to increase 
to 400 million by 2025.(2,3) Approximately 50-80% of 
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the incidence of atopic asthma in the world is triggered 
due to a hypersensitive response to allergens from house 
dust mite (HDMs). Meanwhile, 90% of asthma patients 
in Indonesia are vulnerable to exposure to house dust and 
HDMs. HDMs globally exist in almost all regions and are 
a significant factor underlying bronchial asthma allergies, 
making them the largest source of allergens in the room. 
HDMs affect 2% from the world population, the genus that 
has the greatest influence in Indonesia with high humidity 
is Dermatophagoides pteronyssinus (Der p) of 85% and 
Dermatophagoides farinae (Der f) of 47%.(2,3)
 The pattern of the balance of T Helper1 (pro-
inflammatory type-1), T Helper 2 (pro-type 2 inflammation) 
and the control function of the regulator T expressing anti-
inflammation are referenced as factors that are closely 
related to pathogenesis. The difference in immunity 
sensitization of asthma and non-atopic atopies (normal) to 
allergic symptoms after exposure to HDMs were related to 
a reduced regulatory function of regulatory T cells that work 
through anti-inflammatory pathways. Atopy has an allergen-
specific memory Th cell contrast pattern.(3) HDMs allergy 
Th2 cells play an important role in allergic inflammatory 
responses including production of immunoglobulin E (IgE), 
recruitment  of eosinophils in tissues, mucus production, ease 
of endothelium to recruit inflammatory cells into infected 
lungs, and modulate contractions of respiratory smooth 
muscles. One of the regulatory roles of regulatory T cells 
mediated by interactions with dendritic cells, this interaction 
will produce indoleamine 2,3-dioxygenase (IDO) molecules 
which act as enzymes to control lymphocyte cell growth.
(3) It is expected that the results of this study can contribute 
several approaches in the development of management of 
cases of bronchial asthma due to allergies. 
Methods
The population of this study was moderate persistent 
bronchial asthma and non-atopic asthma subjects. The 
inclusion criteria were subjects aged 30-59 years, living 
in Purwokerto for at least 3 years, and had a history of 
moderate persistent bronchial asthma (for asthma atopic 
subjects), or had no history of asthma and atopy (for non-
atopic subjects). The feasibility of the research ethics study 
had been approved from the Research Ethics Committee of 
the Faculty of Medicine, Universitas Indonesia, No. 1251/
UN2.F1/ETIK/2018.
 The subjects were tested for skin prick test (SPT) 
with HDMs Der p allergen (Stallergenes Company, Kamp-
Lintfort, France). This test was performed on the volar 
area of  the  forearm  with  a  distance  of  at  least  2 
cm  from  the fold of the elbow and wrist. The superficial 
layer of the skin was pierced  using  a  special  needle.  The 
reaction  was considered positive if itching and erythema 
were confirmed by the presence of a distinctive induration 
that could be seen and touched. The largest diameter (D) 
and the smallest diameter (d) is measured by the reaction 
expressed as size (D+d)/2. Measurements were made by 
circling induration with a pen and pasted on a paper before 
the diameter measured.(4,5)
 Each subject was taken venous blood to isolate 
mononuclear cells. PBMCs were blood cells that have 
nuclei, such as lymphocytes, monocytes and macrophages. 
The principle of PBMC isolation were following method 
from Fiqoll Histopaque (Sigma Aldrich, St. Louis, USA), 
where the difference or density gradient between the cell and 
the medium were differentiate into several layers through a 
centrifugation process.(6) PBMCs were given 3 stimulants, 
namely Phytohemagglutinin (PHA) (Sigma Aldrich) as a 
positive control, Roswell Park Memorial Institute (RPMI) 
medium (Sigma Aldrich) as a negative control, and allergen 
extract Der p (Stallergenes Company). About 500.000 cells/
mL PBMCs were cultured on microwell plate 96 wells and 
incubated in 5% CO2 incubator, 37oC for 72 hours. After 72 
hours, the supernatant was taken from each PBMC culture 
by centrifugation.
 Measurement of interleukin (IL)-13, IL-10 and 
interferon (IFN)-γ cytokines in the supernatant were done 
by using Multiplex Immunoassay Luminex (Thermo Fisher 
Scientific, Waltham, USA) with the  results  of  the  data 
in  the  form  of  net  median fluorescent intensity (MFI) 
values then converted through a regression curve from 
each cytokine to obtain cytokines in units of pg/mL. The 
measurement of IDO levels in the supernatant were done 
by using the sandwich enzyme-linked immunosorbent assay 
(ELISA) (Wuhan USCN Business Co, Houston, USA) 
method with the results of the data in the form of optical 
density (OD) and then converted through a standard curve 
from each sample to obtain cytokines in ng/mL unit.
 Data analysis was done by using Windows 8 Statistical 
Package for Social Sciences (SPSS) software version 
22 (IBM, New York, USA) to analyze the relationship of 
variables between patterns of activation of IL-13, IL-10, 
IFN-γ and IDO for people with asthma due to HDMs and 
non-asthma sufferers because of HDMs. To compare the 
cellular responses to HDMs allergens from asthma atopic 
and non-atopic subjects as controls, Mann-Whitney non-
parametric test was done. Meanwhile, non-parametric 
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Spearman Rho correlation test was done to determine the 
magnitude of allergic events to cellular responses.
This in vitro study was conducted on the PBMC culture. 
Total number of subjects in this study was 46 subjects, 
which consist of 25 moderate persistent asthma and positive 
SPT against allergens (atopic asthma) subjects and 21 
subjects who did not suffer from negative asthma and SPT 
on allergens. The characteristics of the subject of this study 
was shown in Table 1. 
 The results of IFN-γ levels measurement from PBMC 
cultures stimulated by PHA (as positive control), RPMI (as 
negative control), and allergen Der p (as allergen factors) 
in the atopic and non-atopic groups were shown in Figure 
1. The mean IFN-γ production value in the positive control 
was not significantly different between groups (p=0.903). 
In the negative control group, IFN-γ production was higher 
in the non-atopic group (p=0.08). Meanwhile and in the 
allergen-stimulated supernatants group, the production of 
IFN-γ  was  found  to  be  higher  in  the  non-atopic  group 
even though it was not statistically significant (p=0.078). 
The comparison of stimulant administration PHA, RPMI 
and Der p in the atopic and non-atopic asthma groups 
showed very  significant  differences  (Kruskal  Wallis  Test, 
p=0.000).
 The measurement  result of IL-13 levels from PBMC 
cultures stimulated by PHA, RPMI and Der p allergens in the 
Results
Total (n) Percentage (%)
Male 14 30.4
Female 32 69.6
45
Positive 25 54.3
Negative 21 45.7
Asthma 25 54.3
Non-asthma 21 45.7
Atopic asthma 25 54.3
Non-atopic asthma 21 45.7
Characteristic
 Gender
 Age, average
 SPT
 Clinical Sign
 Group
Table 1. Characteristics of the research subjects.
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Figure 1. IFN-γ levels from PBMC cultures stimulated 
by PHA (as positive control), RPMI (as negative control), 
and Der p allergens (as allergens) in the atopic and non-
atopic asthma group.
atopic and non-atopic asthma groups were shown in Figure 
2. Figure 2 showed that the mean of IL-13 production in 
positive controls (p=0.522), negative controls (p=0.475) and 
allergens (p=0.523) were not significantly different between 
the atopic and non-atopic asthma. But when looking at the 
mean values IL-13 production, the atopic asthma group 
produced more IL-13 compared to the nonatopic group.
 The measurement results of IL-10 levels from PBMC 
cultures stimulated by PHA, RPMI and Der p allergens  in 
the atopic and non-atopic asthma groups were shown in 
Figure 3. Allergen-stimulated supernatants Der p showed 
IL-10 production results were higher in the non-atopic group 
and were statistically significantly different (p=0.015). 
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Figure 2. IL-13 levels from PBMC cultures stimulated 
by PHA (as positive control), RPMI (as negative control), 
and Der p allergens (as allergens) in the atopic and non-
atopic asthma group.
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Figure 3. IL-10 levels from PBMC cultures stimulated 
by PHA (as positive control), RPMI (as negative control), 
and Der p allergens (as allergens) in the atopic and non-
atopic asthma group.
 The measurement results of IDO levels from PBMC 
cultures stimulated by PHA, RPMI and Der p allergens in the 
atopic and non-atopic asthma groups were shown in Figure 4. 
From Figure 4, it was known that the mean IDO production 
values in positive controls (p=0.462) and negative controls 
(p=0.549) did not differ significantly between groups of 
atopic and non-atopic asthma subjects. But Der p allergen 
stimulated supernatants showed higher IDO production in 
the non-atopic group and statistically significantly different 
(p=0.007). The comparison of stimulant administration 
PHA, RPMI and Der p in the atopic and non-atopic asthma 
groups showed mean differences that tended to be higher 
for stimulant Der p, although statistically not significant 
(Kruskal Wallis Test, p=0.084).
Discussion
The measurement results of IFN-γ levels from PBMC 
cultures stimulated by PHA, RPMI, Der p and allergens 
showed that IFN-γ levels of positive control, negative 
controls, and allergens differing significantly in both the 
atopic and non-atopic asthma groups. This shows that PBMC 
has a good response to stimulation with PHA and Der p 
allergens. The response to PHA as positive control is higher 
because PHA is a nonselective mitogen (can affect various 
types of lymphocyte subpopulations), while allergens 
are selective in T cell lymphocytes.(7,8) Although the 
comparison of intergroup levels did not show a statistically 
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Figure 4. IDO levels from PBMC cultures stimulated by PHA (as positive 
control), RPMI (as negative control), and Der p allergens (as allergens) 
in the atopic and non-atopic asthma group.
significant difference, the trend pattern for producing IFN-γ 
cytokines was higher in the nonatopic group compared with 
the asthma atopy group.
 Der p allergens in the form of cysteine proteases 
have been demonstrated in the previous study to reduce 
the tight junction in epithelial cells of healthy subjects and 
can activate protease-activated receptor (PAR)2 thereby 
inducing E-cadherin disruption in intercellular contacts.
(9) This facilitates allergens to submucosal cells and 
increases allergic inflammation. The decrease in E-cadherin 
in the bronchial epithelium increases the expression 
of proinflammatory factors and promotes Th1 cell 
differentiation. In addition, activation of PAR2 by protease 
induces intracellular signaling activity including nuclear 
factor-ĸB (NFĸB) and extracellular kinase (ERK) signaling 
pathways and there is an increase in IFN-γ proinflammatory 
cytokines as the main effectors.(9-11)
 In the atopic asthma group, IL-13 levels, which are 
Th2 proinflammatory cytokines, were seen to be higher than 
those of the nonatopic group even though the differences 
did not appear to be statistical, but it could be seen the 
tendency of different IL-13 activation patterns in the two 
groups. This is in line with a previous research. It was found 
that Der p can activate toll-like receptor (TLR)4 signal 
transduction  so that it increases the expression of IL-6 and 
major histocompatibility complex (MHC) II which helps the 
process of differentiating naïve T cells into cells Th2.(10,12) 
This is confirmed by a study, which states that Der p which 
has cystein protease allergens can increase the polarization 
of naive T cells into Th2 cells and increase the production of 
proinflammatory cytokines Th2.(9,13) The secretion of Th2 
cytokines has the clinical effect of increasing eosinophil 
recruitment, mast cell activation, and B cell differentiation 
until class-switching becomes IgE. The levels of cytokine 
IL-13 are also a marker that the inflammatory reaction that 
occurs has entered the chronic phase.(9,11) Non-significant 
conditions on IL-13 levels can be caused by the effects 
of asthma exercises carried out by research subjects for 4 
months. Physical exercise can reduce Th2 proinflammatory 
cytokines and increase anti-inflammatory cytokines as 
reported by other studies that was done before.(14,15)
 After analyzing IL-10 activation patterns in two 
groups of subjects, it was found that a higher increase in 
IL-10 levels in the non-atopic group was found compared 
to the atopyic asthma group. Increasing levels of anti-
inflammatory cytokines IL-10 can inhibit the production 
of proinflammatory cytokines through a direct mechanism 
that is towards the immune system effector targets and also 
an indirect mechanism that modulates the function of the 
immune system, for example preventing differentiation of 
dendritic cells. This will inhibit the co-stimulatory process, 
antigen presentation, and decrease the ability of chemokine 
secretion. In addition, increased production of anti-
inflammatory cytokines can also be caused by continued 
proinflammatory production.(16) This has been proved 
before that low IL-10 levels correlate strongly with the 
occurrence of the pathogenesis of asthma.(17)
 The same thing was shown in IDO measurements 
from PBMC cultures stimulated by RPMI, PHA, and Der p 
allergens that IDO levels in the non-atopic group increased 
significantly compared to the atopic group. PBMC cells 
cultured with stimulant antigens derived from Der p 
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allergens can respond in the form of IDO expression, but 
the results can be different if stimulated with other antigens 
because the response is the memory PBMC cell response 
with secondary exposure so that it is specific.(8,11) is an 
enzyme and limits the level of tryptophan (Trp) along the 
kynurenine (Kyn) pathway. IDO is widely expressed in 
various types of cells, including leukocytes and APCs.(18)
 IDO is induced in dendritic (DC) cells, which limits 
inflammation and prevents excessive host responses. Low 
IDO activity has previously been observed in asthma and 
atopic non-asthma patients.(19,20) In several studies, it 
was explained that IDO inhibits airway proinflammation 
mediated by Th2 cells, but does not seem to influence 
tolerance to inhibition in the immune response of 
proinflammatory cells Th1.(20,21,22)
Conclusion
Cellular immune profile of subjects with allergic  asthma  to 
Dermatophagoides  pterronyssinus (Der p) is characterized 
by a type-2 inflammatory response that is dominant 
compared to type-1 inflammation (higher IL-13 ratio 
compared to IFN-γ) and to the role of anti-inflammation 
(higher IL-13 ratio compared to IL-10). The decline in IDO 
production in allergic asthma subjects to Der p is thought to 
be related to the low cellular immune response in expressing 
IFN-γ compared to IL-13.
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